Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 211 articles:
HTML format



Single Articles


    June 2022
  1. MONTINE TJ, Corrada MM, Kawas C, Bukhari S, et al
    Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200832.
    PubMed     Abstract available


  2. PETERSEN KK, Lipton RB, Grober E, Davatzikos C, et al
    Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.
    Neurology. 2022;98:e2425-e2435.
    PubMed     Abstract available


  3. YANG JJ, Keohane LM, Pan X, Qu R, et al
    Association of Healthy Lifestyles with Risk of Alzheimer Disease and Related Dementias in Low-Income Black and White Americans.
    Neurology. 2022 Jun 13. pii: WNL.0000000000200774.
    PubMed     Abstract available


  4. TANG B, Wang Y, Jiang X, Thambisetty M, et al
    Genetic Variation in Targets of Anti-diabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study.
    Neurology. 2022 Jun 2. pii: WNL.0000000000200771.
    PubMed     Abstract available


    May 2022
  5. KUMAR A, Janelidze S, Stomrud E, Palmqvist S, et al
    beta-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.
    Neurology. 2022 May 31. pii: WNL.0000000000200605.
    PubMed     Abstract available


  6. DUMURGIER J, Sabia S, Zetterberg H, Teunissen C, et al
    Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022 May 26. pii: WNL.0000000000200735.
    PubMed     Abstract available


  7. MOHANTY R, Ferreira D, Frerich S, Muehlboeck JS, et al
    Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Neurology. 2022 May 24. pii: WNL.0000000000200573.
    PubMed     Abstract available


  8. MCGIRR A, Nathan S, Ghahremani M, Gill S, et al
    Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
    Neurology. 2022;98:e2132-e2139.
    PubMed     Abstract available


  9. XICOTA L, Gyorgy B, Grenier-Boley B, Lecoeur A, et al
    Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.
    Neurology. 2022 May 23. pii: WNL.0000000000200544.
    PubMed     Abstract available


  10. FARNSWORTH VON CEDERWALD B, Josefsson M, Wahlin A, Nyberg L, et al
    Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia.
    Neurology. 2022;98:e2013-e2022.
    PubMed     Abstract available


  11. LI Z, Heckman MG, Kanekiyo T, Martens YA, et al
    Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment.
    Neurology. 2022;98:e2036-e2045.
    PubMed     Abstract available


  12. ASKEN BM, Tanner JA, VandeVrede L, Mantyh WG, et al
    Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
    Neurology. 2022 May 16. pii: WNL.0000000000200678.
    PubMed     Abstract available


  13. AGOSTA F, Filippi M
    Natural Speech Analysis: A Window Into Alzheimer Disease Phenotypes.
    Neurology. 2022 May 4. pii: WNL.0000000000200843.
    PubMed    


  14. BEYDOUN MA, Beydoun HA, Fanelli-Kuczmarski MT, Weiss J, et al
    Association of Serum Antioxidant Vitamins and Carotenoids With Incident Alzheimer Disease and All-Cause Dementia Among US Adults.
    Neurology. 2022 May 4. pii: WNL.0000000000200289.
    PubMed     Abstract available


    April 2022
  15. CHO S, Quilico Cousins KA, Shellikeri S, Ash S, et al
    Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology.
    Neurology. 2022 Apr 29. pii: WNL.0000000000200581.
    PubMed     Abstract available


  16. WHITWELL J, Martin PR, Graff-Radford J, Machulda M, et al
    Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200336.
    PubMed     Abstract available


  17. VOGEL JW, Tosun D
    Multiple Cortical to Striatal Accumulation Trajectories of beta-Amyloid: Do All Roads Lead to Rome?
    Neurology. 2022;98:695-696.
    PubMed    


  18. COLLIJ LE, Salvado G, Wottschel V, Mastenbroek SE, et al
    Spatial-Temporal Patterns of beta-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis.
    Neurology. 2022;98:e1692-e1703.
    PubMed     Abstract available


  19. BEAUDIN AE, McCreary CR, Mazerolle EL, Gee M, et al
    Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.
    Neurology. 2022;98:e1716-e1728.
    PubMed     Abstract available


  20. ARANHA MR, Fortea J, Carmona-Iragui M
    Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200704.
    PubMed    


  21. FRANK B, Ally M, Tripodis Y, Puzo C, et al
    Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease.
    Neurology. 2022 Apr 20. pii: WNL.0000000000200304.
    PubMed     Abstract available


  22. BEAMAN C, Kozii K, Hilal S, Liu M, et al
    Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration.
    Neurology. 2022;98:e1605-e1616.
    PubMed     Abstract available


  23. DIFRANCESCO JC, Stanzani L
    Increased Brain Volume: A Novel Biomarker of Neurodegeneration?
    Neurology. 2022;98:649-650.
    PubMed    


  24. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200302.
    PubMed     Abstract available


  25. GRAFF-RADFORD J, Josephs K
    Author Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:644.
    PubMed    


  26. DASHEIFF R
    Reader Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:643.
    PubMed    


  27. SIEGLER JE 3RD, Galetta S
    Editors' Note: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:643.
    PubMed    


  28. FARRELL ME, Papp KV, Buckley RF, Jacobs HIL, et al
    Association of Emerging beta-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Neurology. 2022;98:e1512-e1524.
    PubMed     Abstract available


  29. TIDEMAN P, Stomrud E, Leuzy A, Mattsson-Carlgren N, et al
    Association of beta-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Neurology. 2022;98:e1525-e1533.
    PubMed     Abstract available


  30. GAUTHREAUX KM, Teylan MA, Katsumata Y, Mock C, et al
    Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Neurology. 2022;98:e1422-e1433.
    PubMed     Abstract available


  31. GU Y, Kociolek A, Fernandez KK, Cosentino SA, et al
    Clinical Trajectories at the End of Life in Dementia Patients With Alzheimer Disease and Lewy Body Neuropathologic Changes.
    Neurology. 2022 Apr 4. pii: WNL.0000000000200259.
    PubMed     Abstract available


    March 2022
  32. GUAN Y, Ebrahimzadeh SA, Cheng CH, Chen W, et al
    Association of Diabetes and Hypertension With Brain Structural Integrity and Cognition in the Boston Puerto Rican Health Study Cohort.
    Neurology. 2022 Mar 30. pii: WNL.0000000000200120.
    PubMed     Abstract available


  33. ZAMMIT AR, Yu L, Petyuk V, Schneider JA, et al
    Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults.
    Neurology. 2022;98:e1304-e1314.
    PubMed     Abstract available


  34. SALINAS J, Beiser AS, Samra JK, O'Donnell A, et al
    Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline.
    Neurology. 2022;98:e1337-e1348.
    PubMed     Abstract available


  35. PETERSEN RC
    Detecting Alzheimer Disease Clinically: How Early Can We Go?
    Neurology. 2022 Mar 25. pii: WNL.0000000000200172.
    PubMed    


  36. VAN DE BEEK M, Ooms FAH, Ebenau JL, Barkhof F, et al
    Association of the ATN Research Framework With Clinical Profile, Cognitive Decline, and Mortality in Patients With Dementia With Lewy Bodies.
    Neurology. 2022;98:e1262-e1272.
    PubMed     Abstract available


  37. VAN LOENHOUD AC, Groot C, Bocancea DI, Barkhof F, et al
    Association of Education and Intracranial Volume With Cognitive Trajectories and Mortality Rates Across the Alzheimer Disease Continuum.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200116.
    PubMed     Abstract available


  38. JOSEPHS KA, Weigand SD, Whitwell J
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200287.
    PubMed     Abstract available


  39. HESHMATOLLAH A, Fani L, Koudstaal PJ, Ghanbari M, et al
    Plasma Amyloid Beta, Total-Tau and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study.
    Neurology. 2022 Mar 1. pii: WNL.0000000000200004.
    PubMed     Abstract available


    February 2022
  40. DAY GS, Scarmeas N, Dubinsky R, Coerver K, et al
    Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: Report of the AAN Guidelines Subcommittee.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200176.
    PubMed     Abstract available


  41. GROBER E, Lipton RB, Sperling RA, Papp KV, et al
    Associations of Stages of Objective Memory Impairment (SOMI) with Amyloid PET and Structural MRI: The A4 Study.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200046.
    PubMed     Abstract available


  42. MATTSSON-CARLGREN N, Grinberg LT, Boxer A, Ossenkoppele R, et al
    Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Neurology. 2022 Feb 16. pii: WNL.0000000000200040.
    PubMed     Abstract available


  43. CHU WT, Wang WE, Zaborszky L, Golde TE, et al
    Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.
    Neurology. 2022;98:e700-e710.
    PubMed     Abstract available


  44. EBENAU JL, Pelkmans W, Verberk IMW, Verfaillie S, et al
    Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
    Neurology. 2022 Feb 2. pii: WNL.0000000000200035.
    PubMed     Abstract available


    January 2022
  45. BOWN CW, Carare RO, Schrag MS, Jefferson AL, et al
    Physiology and Clinical Relevance of Enlarged Perivascular Spaces in the Aging Brain.
    Neurology. 2022;98:107-117.
    PubMed     Abstract available


  46. WHITTINGTON MD, Campbell JD, Rind D, Fluetsch N, et al
    Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.
    Neurology. 2022 Jan 12. pii: WNL.0000000000013314.
    PubMed     Abstract available


  47. BALLARINI T, Melo van Lent D, Wagner M
    Author Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:89-90.
    PubMed    


  48. GANESH A, Galetta S
    Editors' Note: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:88.
    PubMed    


  49. BRENNER SR
    Reader Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:88-89.
    PubMed    


  50. DA SILVA SOYOMBO NK, Rocha EL, Xavier LB, Oliveira RA, et al
    Biomarkers for Differential Diagnosis Between Chronic Traumatic Encephalopathy and Alzheimer Disease: A Systematic Review.
    Neurology. 2022;98.
    PubMed     Abstract available


    December 2021
  51. YOO HS, Jeon S, Cavedo E, Ko M, et al
    Association of beta-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
    Neurology. 2021 Dec 30. pii: WNL.0000000000013277.
    PubMed     Abstract available


  52. CULLEN N, Janelidze S, Palmqvist S, Stomrud E, et al
    Association of CSF Abeta38 Levels With Risk of Alzheimer Disease-Related Decline.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013228.
    PubMed     Abstract available


  53. YU L, Boyle PA, Wingo AP, Yang J, et al
    Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013252.
    PubMed     Abstract available


  54. LI Y, Schindler SE, Bollinger JG, Ovod V, et al
    Validation of Plasma Amyloid-beta 42/40 for Detecting Alzheimer Disease Amyloid Plaques.
    Neurology. 2021 Dec 14. pii: WNL.0000000000013211.
    PubMed     Abstract available


    November 2021
  55. SMIRNOV DS, Salmon DP, Galasko D, Goodwill VS, et al
    Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.
    Neurology. 2021 Nov 22. pii: WNL.0000000000013107.
    PubMed     Abstract available


  56. ACOSTA LM
    I Wasn't There: Caring for a Patient With Trisomy 21, Alzheimer Disease, and Epilepsy Until His Final Days With COVID-19.
    Neurology. 2021 Nov 22. pii: WNL.0000000000013109.
    PubMed     Abstract available


  57. CHIONG W, Tolchin BD, Bonnie RJ, Busl K, et al
    Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.
    Neurology. 2021 Nov 17. pii: WNL.0000000000013053.
    PubMed    


  58. KUSCHPEL MS
    Reader Response: Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Neurology. 2021;97:964-965.
    PubMed    


  59. SCHELBAUM E, Loughlin L, Jett S, Zang C, et al
    Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife.
    Neurology. 2021 Nov 3. pii: WNL.0000000000012941.
    PubMed     Abstract available


    October 2021
  60. LEUZY A, Janelidze S, Mattsson-Carlgren N, Palmqvist S, et al
    Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
    Neurology. 2021;97:e1681-e1694.
    PubMed     Abstract available


    September 2021
  61. KIM YJ, Karceski S
    Alzheimer Disease and Mood.
    Neurology. 2021;97:e1363-e1366.
    PubMed    


  62. EDMONDS EC, Smirnov DS, Thomas KR, Graves LV, et al
    Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes.
    Neurology. 2021;97:e1288-e1299.
    PubMed     Abstract available


  63. MILA-ALOMA M, Brinkmalm A, Ashton NJ, Kvartsberg H, et al
    CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012853.
    PubMed     Abstract available


  64. GARNIER-CRUSSARD A, Krolak-Salmon P
    Reader Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;97:608.
    PubMed    


  65. THERRIAULT J, Pascoal T, Gauthier S, Rosa-Neto P, et al
    Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;97:609.
    PubMed    


  66. JEONG SH, Kim HR, Kim J, Kim H, et al
    Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.
    Neurology. 2021;97:e1110-e1122.
    PubMed     Abstract available


  67. HERSHEY LA, Tarawneh R
    Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?
    Neurology. 2021;97:517-518.
    PubMed    


  68. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    PubMed     Abstract available


  69. BUCIUC M, Josephs KA, Jones DT, Whitwell JL, et al
    Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012783.
    PubMed    


  70. MCCARTER S, Lesnick TG, Lowe V, Mielke MM, et al
    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012770.
    PubMed     Abstract available


    August 2021
  71. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    PubMed     Abstract available


  72. SANDERS AE
    A Century-Old Problem: Cognition and Neuropsychiatric Symptoms in Alzheimer Disease.
    Neurology. 2021 Aug 20. pii: WNL.0000000000012616.
    PubMed    


  73. EIKELBOOM WS, van den Berg E, Singleton EH, Baart SJ, et al
    Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Neurology. 2021 Aug 19. pii: WNL.0000000000012598.
    PubMed     Abstract available


  74. LI J
    Alzheimer's Villanelle.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012612.
    PubMed    


  75. PETERSEN RC
    Mild Cognitive Impairment Criteria in Alzheimer's Disease Neuroimaging Initiative: Meeting Biological Expectations.
    Neurology. 2021 Aug 2. pii: WNL.0000000000012588.
    PubMed    


    July 2021
  76. TAO Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, et al
    Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E varepsilon4 Carriers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012512.
    PubMed     Abstract available


  77. BOCANCEA DI, Catharina van Loenhoud A, Groot C, Barkhof F, et al
    Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012499.
    PubMed     Abstract available


  78. GROTHE MJ, Moscoso A, Ashton NJ, Karikari TK, et al
    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012513.
    PubMed     Abstract available


  79. POGGESI A
    Resilience and Resistance in Aging and Alzheimer Disease: Another Step to Fill the Gap Between Clinicians and Researchers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012500.
    PubMed    


  80. WILSON RS, Wang T, Yu L, Grodstein F, et al
    Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012388.
    PubMed     Abstract available


  81. SALLOWAY S, Cummings J
    Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012451.
    PubMed    


    June 2021
  82. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    PubMed     Abstract available


  83. JUTTEN RJ, Sikkes SAM, Van der Flier WM, Scheltens P, et al
    Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity.
    Neurology. 2021;96:e2673-e2684.
    PubMed     Abstract available


  84. BUCKLEY RF, Knopman DS
    Cognitive Heterogeneity in Alzheimer Clinical Trials: Harnessing Noise to Achieve Meaningfulness.
    Neurology. 2021;96:1017-1018.
    PubMed    


    May 2021
  85. HUGHES TM, Hajjar I
    Is Late-onset Alzheimer Disease Spelled "ATV(N)"?
    Neurology. 2021 May 24. pii: WNL.0000000000012259.
    PubMed    


  86. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    PubMed     Abstract available


  87. FRIEDMAN LG, McKeehan N, Hara Y, Cummings JL, et al
    Value-Generating Exploratory Trials in Neurodegenerative Dementias.
    Neurology. 2021;96:944-954.
    PubMed     Abstract available


  88. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    PubMed     Abstract available


  89. BALLARINI T, Melo van Lent D, Brunner J, Schroder A, et al
    Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.
    Neurology. 2021 May 5. pii: WNL.0000000000012067.
    PubMed     Abstract available


  90. BELLAVER B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, et al
    Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021 May 5. pii: WNL.0000000000012109.
    PubMed     Abstract available


  91. HAZRATI LN, Schwab N
    Embracing the Unknown in the Diagnosis of Traumatic Encephalopathy Syndrome.
    Neurology. 2021;96:835-836.
    PubMed    


    April 2021
  92. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    PubMed     Abstract available


  93. KARCESKI S
    The Effects of Long-term Medication Use in Alzheimer Disease.
    Neurology. 2021;96:e2247-e2250.
    PubMed    


  94. XU H, Garcia-Ptacek S, Jonsson L, Wimo A, et al
    Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Neurology. 2021;96:e2220-e2230.
    PubMed     Abstract available


  95. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    PubMed     Abstract available


  96. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease.
    Neurology. 2021 Apr 19. pii: WNL.0000000000012024.
    PubMed     Abstract available


  97. HOWARD E, Irwin DJ, Rascovsky K, Nevler N, et al
    Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
    Neurology. 2021;96:e1855-e1864.
    PubMed     Abstract available


    March 2021
  98. QIAN J, Betensky RA, Hyman BT, Serrano-Pozo A, et al
    Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
    Neurology. 2021 Mar 26. pii: WNL.0000000000011883.
    PubMed     Abstract available


  99. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.
    PubMed    


  100. KANG SH, Kim ME, Jang H, Kwon H, et al
    Amyloid Positivity in Alzheimer/Subcortical-Vascular Spectrum.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011833.
    PubMed     Abstract available


  101. SMIRNOV DS, Galasko D, Hiniker A, Edland S, et al
    Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011772.
    PubMed     Abstract available


  102. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    PubMed    


    February 2021
  103. ROBINSON-PAPP J, Saylor D
    HIV in the Brain: From Devastating Dementia to White Matter Hyperintensities.
    Neurology. 2021 Feb 26. pii: WNL.0000000000011735.
    PubMed    


  104. HUYNH K, Piguet O, Kwok J, Dobson-Stone C, et al
    Clinical and Biological Correlates of White Matter Hyperintensities in Patients with Behavioral-variant Frontotemporal Dementia and Alzheimer Disease.
    Neurology. 2021 Feb 17. pii: WNL.0000000000011638.
    PubMed     Abstract available


  105. THERRIAULT J, Pascoal TA, Benedet AL, Tissot C, et al
    Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;96:e975-e985.
    PubMed     Abstract available


  106. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    PubMed     Abstract available


  107. DETERS K, Napolioni V, Sperling RA, Greicius MD, et al
    Amyloid PET imaging in self-identified non-Hispanic Blacks from the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011599.
    PubMed     Abstract available


  108. FERREIRA D, Nordberg A, Westman E
    Author Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:238.
    PubMed    


  109. ULEMAN JF, Melis RJF, Olde Rikkert MGM
    Reader Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237-238.
    PubMed    


  110. GANESH A, Galetta S
    Editors' Note: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237.
    PubMed    


    January 2021
  111. JOSEPH-MATHURIN N, Wang G, Kantarci K, Jack CR Jr, et al
    Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.
    Neurology. 2021 Jan 25. pii: WNL.0000000000011542.
    PubMed     Abstract available


  112. SAJJADI SA, Ash S, Cappa S
    Glass half full: Preservation of memory in Alzheimer-related primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011404.
    PubMed    


  113. MESULAM MM, Coventry C, Kuang A, Bigio EH, et al
    Memory resilience in Alzheimer's disease with primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011397.
    PubMed     Abstract available


  114. BLAZHENETS G, Frings L, Ma Y, Sorensen A, et al
    Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011521.
    PubMed     Abstract available


  115. JAGUST WJ, Landau SM
    Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011524.
    PubMed     Abstract available


  116. TRELLE AN, Carr VA, Wilson EN, Swarovski MS, et al
    Association of CSF Biomarkers with Hippocampal-dependent Memory in Preclinical Alzheimer Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011477.
    PubMed     Abstract available


  117. THERRIAULT J, Pascoal TA, Savard M, Benedet AL, et al
    Topographic Distribution of Amyloid-beta, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease.
    Neurology. 2021;96:e81-e92.
    PubMed     Abstract available


    December 2020
  118. KNOPMAN DS, Jagust WJ
    Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011415.
    PubMed    


  119. KOYAMA AK, Irwin DJ
    Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?
    Neurology. 2020;95:1076-1077.
    PubMed    


  120. GICAS KM, Honer WG, Wilson RS, Boyle PA, et al
    Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes.
    Neurology. 2020;95:e3303-e3312.
    PubMed     Abstract available


  121. PETTIGREW C, Soldan A, Wang J, Wang MC, et al
    Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline.
    Neurology. 2020;95:e3093-e3103.
    PubMed     Abstract available


  122. PALMQVIST S, Eshaghi A
    Spatial distribution of tau and beta-amyloid pathologies and their role in different Alzheimer's disease phenotypes.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011272.
    PubMed    


  123. LA JOIE R, Visani AV, Lesman-Segev OH, Baker SL, et al
    Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011270.
    PubMed     Abstract available


    November 2020
  124. KARCESKI S
    How a buildup of abnormal proteins in the brain may be the key to understanding Alzheimer disease.
    Neurology. 2020;95:e2951-e2953.
    PubMed    


  125. YOUNAN D, Wang X, Casanova R, Barnard R, et al
    PM2.5 associated with gray matter atrophy reflecting increased Alzheimers risk in older women.
    Neurology. 2020 Nov 18. pii: WNL.0000000000011149.
    PubMed     Abstract available


  126. ILLAN-GALA I, Lleo A, Karydas A, Staffaroni AM, et al
    Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011226.
    PubMed     Abstract available


  127. GRAFF-RADFORD J, Knopman D, Jones D
    Author response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:846.
    PubMed    


  128. ALLALI G, Laticevschi T
    Reader response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845-846.
    PubMed    


  129. SIEGLER JE 3RD, Galetta S
    Editors' note: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845.
    PubMed    


    October 2020
  130. KIM HR, Lee T, Choi JK, Jeong Y, et al
    Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
    Neurology. 2020;95:e2366-e2377.
    PubMed     Abstract available


  131. WEIGAND AJ, Bondi MW, Thomas KR, Campbell NL, et al
    Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.
    Neurology. 2020;95:e2295-e2304.
    PubMed     Abstract available


  132. KERCHNER GA, Filippi M
    Abeta-PET pathology accumulation index: Ready for the clinic?
    Neurology. 2020 Oct 19. pii: WNL.0000000000011060.
    PubMed    


  133. LEUZY A, Lilja J, Buckley CJ, Ossenkoppele R, et al
    Derivation and utility of an Abeta-PET pathology accumulation index to estimate Abeta load.
    Neurology. 2020 Oct 19. pii: WNL.0000000000011031.
    PubMed     Abstract available


  134. BENNETT DA, Knopman DS
    Extending Alzheimer disease biomarker studies into the Hispanic community.
    Neurology. 2020;95:665-666.
    PubMed    


  135. NAG S, Barnes LL, Yu L, Wilson RS, et al
    Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents.
    Neurology. 2020;95:e2056-e2064.
    PubMed     Abstract available


  136. GERTJE EC, van Westen D, Panizo C, Mattsson-Carlgren N, et al
    Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011046.
    PubMed    


  137. KAPASI A, Yu L, Boyle PA, Barnes LL, et al
    Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.
    Neurology. 2020;95:e1951-e1962.
    PubMed     Abstract available


  138. CATRICALA E, Polito C, Presotto L, Esposito V, et al
    Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010967.
    PubMed     Abstract available


    September 2020
  139. HANES J, Kovac A, Kvartsberg H, Kontsekova E, et al
    Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias.
    Neurology. 2020 Sep 24. pii: WNL.0000000000010814.
    PubMed     Abstract available


  140. BRENOWITZ WD, Besser LM, Kukull WA, Keene CD, et al
    Clinician-judged hearing impairment and associations with neuropathologic burden.
    Neurology. 2020;95:e1640-e1649.
    PubMed     Abstract available


  141. SAN LEE J, Lee H, Park S, Choe Y, et al
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology. 2020 Sep 14. pii: WNL.0000000000010811.
    PubMed     Abstract available


  142. CIRRITO JR, Wallace CE, Yan P, Davis TA, et al
    Effect of Escitalopram on Abeta levels and plaque load in an Alzheimer mouse model.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010733.
    PubMed     Abstract available


  143. SCHREIBER S, DiFrancesco JC
    Impaired occipital cerebrovascular reactivity as a biomarker for vascular beta-amyloid.
    Neurology. 2020;95:415-416.
    PubMed    


  144. GUZMAN-VELEZ E, Martinez J, Papp K, Baena A, et al
    Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Neurology. 2020;95:e1312-e1321.
    PubMed     Abstract available


  145. BRENOWITZ WD, Filshtein TJ, Yaffe K, Walter S, et al
    Association of genetic risk for Alzheimer disease and hearing impairment.
    Neurology. 2020 Sep 2. pii: WNL.0000000000010709.
    PubMed     Abstract available


  146. LUO J, Agboola F, Grant E, Masters CL, et al
    Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
    Neurology. 2020 Sep 1. pii: WNL.0000000000010747.
    PubMed     Abstract available


    August 2020
  147. HUANG J, Zuber V, Matthews PM, Elliott P, et al
    Sleep, major depressive disorder and Alzheimer's disease: A Mendelian randomisation study.
    Neurology. 2020 Aug 19. pii: WNL.0000000000010463.
    PubMed     Abstract available


  148. KIM JW, Byun MS, Lee JH, Yi D, et al
    Serum albumin and beta-amyloid deposition in the human brain.
    Neurology. 2020;95:e815-e826.
    PubMed     Abstract available


  149. MOFRAD RB, Tijms BM, Scheltens P, Barkhof F, et al
    Sex differences in CSF biomarkers vary by Alzheimer's disease stage and APOE epsilon4 genotype.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010629.
    PubMed     Abstract available


  150. VAN DER ZANDE JJ, Gouw AA, van Steenoven I, van de Beek M, et al
    Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    Neurology. 2020;95:e662-e670.
    PubMed     Abstract available


  151. LAM AD, Sarkis RA, Pellerin KR, Jing J, et al
    Association of epileptiform abnormalities and seizures in Alzheimer disease.
    Neurology. 2020 Aug 6. pii: WNL.0000000000010612.
    PubMed     Abstract available


  152. GONNEAUD J, Bedetti C, Binette AP, Benzinger TLS, et al
    Association of education with Abeta burden in preclinicial familial and sporadic Alzheimer disease.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010314.
    PubMed     Abstract available


    July 2020
  153. ARENAZA-URQUIJO EM EM, Salvado G, Operto G, Minguillon C, et al
    Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers.
    Neurology. 2020 Jul 31. pii: WNL.0000000000010527.
    PubMed     Abstract available


  154. BAUMEISTER SE, Karch A, Bahls M, Teumer A, et al
    Physical activity and risk of Alzheimer's disease: a two-sample Mendelian randomization study.
    Neurology. 2020 Jul 17. pii: WNL.0000000000010013.
    PubMed     Abstract available


  155. COLLIJ LE, Heeman F, Salvado G, Ingala S, et al
    Multi-tracer model for staging cortical amyloid deposition using PET imaging.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010256.
    PubMed     Abstract available


  156. SAIF N, Niotis K, Dominguez M, Hodes JF, et al
    Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial.
    Neurology. 2020 Jul 14. pii: WNL.0000000000009859.
    PubMed     Abstract available


  157. SUR S, Lin Z, Li Y, Yasar S, et al
    Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.
    Neurology. 2020 Jul 13. pii: WNL.0000000000010133.
    PubMed     Abstract available


  158. SWITZER AR, Cheema I, McCreary CR, Zwiers A, et al
    Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010201.
    PubMed     Abstract available


  159. EBENAU JL, Timmers T, Wesselman LMP, Verberk IMW, et al
    ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.
    Neurology. 2020;95:e46-e58.
    PubMed     Abstract available


  160. SAKAE N, Santos OA, Pedraza O, Litvan I, et al
    Clinical and pathologic features of cognitive-predominant corticobasal degeneration.
    Neurology. 2020;95:e35-e45.
    PubMed     Abstract available


  161. TEIPEL SJ, Fritz HC, Grothe MJ
    Neuropathological features associated with basal forebrain atrophy in Alzheimer's disease.
    Neurology. 2020 Jul 6. pii: WNL.0000000000010192.
    PubMed     Abstract available


  162. WOLTERS FJ, Chibnik LB, Waziry R, Anderson R, et al
    27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium.
    Neurology. 2020 Jul 1. pii: WNL.0000000000010022.
    PubMed     Abstract available


    June 2020
  163. TIBLE M, Sandelius A, Hoglund K, Brinkmalm A, et al
    Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.
    Neurology. 2020 Jun 25. pii: WNL.0000000000010131.
    PubMed     Abstract available


  164. RAHMAN A, Schelbaum E, Hoffman K, Diaz I, et al
    Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Neurology. 2020 Jun 24. pii: WNL.0000000000009781.
    PubMed     Abstract available


  165. DHANA K, Evans DA, Rajan KB, Bennett DA, et al
    Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies.
    Neurology. 2020 Jun 17. pii: WNL.0000000000009816.
    PubMed     Abstract available


  166. BUCIUC M, Botha H, Murray ME, Schwarz CG, et al
    Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
    Neurology. 2020 Jun 9. pii: WNL.0000000000009722.
    PubMed     Abstract available


  167. QIN L, Zhu X, Friedland RP
    ApoE and mitochondrial dysfunction.
    Neurology. 2020;94:1009-1010.
    PubMed    


    May 2020
  168. YIN J, Reiman EM, Beach TG, Serrano GE, et al
    Effect of ApoE isoforms on mitochondria in Alzheimer disease.
    Neurology. 2020 May 26. pii: WNL.0000000000009582.
    PubMed     Abstract available


  169. MATTSSON-CARLGREN N, Leuzy A, Janelidze S, Palmqvist S, et al
    The implications of different approaches to define AT(N) in Alzheimer disease.
    Neurology. 2020 May 12. pii: WNL.0000000000009485.
    PubMed     Abstract available


  170. JACOBS HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, et al
    The presubiculum links incipient amyloid and tau pathology to memory function in older persons.
    Neurology. 2020;94:e1916-e1928.
    PubMed     Abstract available


  171. BERNATH MM, Bhattacharyya S, Nho K, Barupal DK, et al
    Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers.
    Neurology. 2020 May 1. pii: WNL.0000000000009436.
    PubMed     Abstract available


    April 2020
  172. SMIRNOV DS, Galasko D, Edland SD, Filoteo JV, et al
    Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.
    Neurology. 2020 Apr 24. pii: WNL.0000000000009434.
    PubMed     Abstract available


  173. SARYCHEVA T, Lavikainen P, Taipale H, Tiihonen J, et al
    Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009435.
    PubMed     Abstract available


  174. VILAPLANA E, Rodriguez-Vieitez E, Ferreira D, Montal V, et al
    Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease.
    Neurology. 2020 Apr 14. pii: WNL.0000000000009405.
    PubMed     Abstract available


  175. ARENAZA-URQUIJO EM, Przybelski SA, Machulda MM, Knopman DS, et al
    Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults.
    Neurology. 2020;94:e1571-e1579.
    PubMed     Abstract available


    March 2020
  176. BREITNER J, Meyer PF
    Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:594.
    PubMed    


  177. ASHFORD JW
    Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593-594.
    PubMed    


  178. GANESH A, Galetta S
    Editors' note: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593.
    PubMed    


  179. DOECKE JD, Perez-Grijalba V, Fandos N, Fowler C, et al
    Total Abeta42/Abeta40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.
    Neurology. 2020 Mar 16. pii: WNL.0000000000009240.
    PubMed     Abstract available


  180. TERADA T, Obi T, Bunai T, Matsudaira T, et al
    In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009249.
    PubMed     Abstract available


  181. SWERDLOW RH
    Mitochondria in Alzheimer brains: A PET project shows complex changes.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009236.
    PubMed    


    February 2020
  182. FERREIRA D, Nordberg A, Westman E
    Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.
    Neurology. 2020 Feb 11. pii: WNL.0000000000009058.
    PubMed     Abstract available


  183. HAAKSMA ML, Eriksdotter M, Rizzuto D, Leoutsakos JS, et al
    Survival time tool to guide care planning in people with dementia.
    Neurology. 2020;94:e538-e548.
    PubMed     Abstract available


  184. MCSWEENEY M, Pichet Binette A, Meyer PF, Gonneaud J, et al
    Intermediate flortaucipir uptake is associated with Abeta-PET and CSF-tau in asymptomatic adults.
    Neurology. 2020 Feb 3. pii: WNL.0000000000008905.
    PubMed     Abstract available


    January 2020
  185. RESENDE EPF, Nolan AL, Petersen C, Ehrenberg AJ, et al
    Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes: Astrocytic tau, cognitive function, and Alzheimer disease.
    Neurology. 2020 Jan 30. pii: WNL.0000000000008937.
    PubMed     Abstract available


  186. HOLLAND TM, Agarwal P, Wang Y, Leurgans SE, et al
    Dietary flavonols and risk of Alzheimer dementia.
    Neurology. 2020 Jan 29. pii: WNL.0000000000008981.
    PubMed     Abstract available


  187. MARTERSTECK A, Sridhar J, Rader B, Coventry C, et al
    Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease.
    Neurology. 2020 Jan 22. pii: WNL.0000000000008960.
    PubMed     Abstract available


  188. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:144-145.
    PubMed    


  189. NELSON P
    Reader response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143-144.
    PubMed    


  190. SIEGLER JE 3RD, Galetta S
    Editors' note: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143.
    PubMed    


  191. WAZIRY R, Chibnik LB, Bos D, Ikram MK, et al
    Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.
    Neurology. 2020 Jan 16. pii: WNL.0000000000008924.
    PubMed     Abstract available


  192. YU L, Boyle PA, Dawe RJ, Bennett DA, et al
    Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.
    Neurology. 2020;94:e142-e152.
    PubMed     Abstract available


    December 2019
  193. SOLDAN A, Pettigrew C, Zhu Y, Wang MC, et al
    White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Neurology. 2019 Dec 30. pii: WNL.0000000000008864.
    PubMed     Abstract available


  194. CAVEDO E, Lista S, Houot M, Vergallo A, et al
    Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Neurology. 2019 Dec 4. pii: WNL.0000000000008696.
    PubMed     Abstract available


    November 2019
  195. HONDA T, Ohara T, Shinohara M, Hata J, et al
    Serum elaidic acid concentration and risk of dementia: The Hisayama Study.
    Neurology. 2019;93:e2053-e2064.
    PubMed     Abstract available


  196. GRAFF-RADFORD J, Gunter JL, Jones DT, Przybelski SA, et al
    Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008616.
    PubMed     Abstract available


  197. WEINTRAUB S, Teylan M, Rader B, Chan KCG, et al
    APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
    Neurology. 2019 Nov 8. pii: WNL.0000000000008666.
    PubMed     Abstract available


    October 2019
  198. NETH BJ
    Right brain: Art and the restoration of identity in dementia.
    Neurology. 2019;93:719-721.
    PubMed    


  199. CHONG JSX, Jang H, Kim HJ, Ng KK, et al
    Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.
    Neurology. 2019;93:e1514-e1525.
    PubMed     Abstract available


  200. SCHNEIDER LS, Geffen Y, Rabinowitz J, Thomas RG, et al
    Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial.
    Neurology. 2019;93:e1474-e1484.
    PubMed     Abstract available


  201. MIRZA SS, Saeed U, Knight J, Ramirez J, et al
    APOE varepsilon4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.
    Neurology. 2019 Oct 1. pii: WNL.0000000000008377.
    PubMed     Abstract available


    July 2019
  202. WOLTERS FJ, Zonneveld HI, Licher S, Cremers LGM, et al
    Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI.
    Neurology. 2019 Jul 31. pii: WNL.0000000000008003.
    PubMed     Abstract available


  203. BISCHOF GN, Jacobs HIL
    Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
    Neurology. 2019;93:72-79.
    PubMed     Abstract available


    June 2019
  204. TAGHDIRI F, Multani N, Tarazi A, Naeimi SA, et al
    Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions.
    Neurology. 2019;92:e2717-e2726.
    PubMed     Abstract available


    April 2019
  205. SOLDAN A, Pettigrew C, Fagan AM, Schindler SE, et al
    ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.
    Neurology. 2019;92:e1567-e1579.
    PubMed     Abstract available


    March 2019
  206. SATHYAN S, Wang T, Ayers E, Verghese J, et al
    Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study.
    Neurology. 2019;92:e1427-e1434.
    PubMed     Abstract available


  207. PRESSMAN PS, Gola K, Shdo SM, Miller BL, et al
    Relative preservation of facial expression recognition in posterior cortical atrophy.
    Neurology. 2019;92:e1064-e1071.
    PubMed     Abstract available


    February 2019
  208. WILSON RS, Yang J, Yu L, Leurgans SE, et al
    Postmortem neurodegenerative markers and trajectories of decline in cognitive systems.
    Neurology. 2019;92:e831-e840.
    PubMed     Abstract available


  209. MORAN C, Beare R, Wang W, Callisaya M, et al
    Type 2 diabetes mellitus, brain atrophy, and cognitive decline.
    Neurology. 2019;92:e823-e830.
    PubMed     Abstract available


  210. BUCHMAN AS, Yu L, Wilson RS, Lim A, et al
    Physical activity, common brain pathologies, and cognition in community-dwelling older adults.
    Neurology. 2019;92:e811-e822.
    PubMed     Abstract available


    January 2019
  211. WHITWELL JL, Martin PR, Duffy JR, Clark HM, et al
    The influence of beta-amyloid on [(18)F]AV-1451 in semantic variant of primary progressive aphasia.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006913.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: